Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas
Author(s) -
P. Wang,
Q. Dong,
C. Zhang,
Pei Fen Kuan,
Yali Liu,
William R. Jeck,
J. B. Andersen,
W. Jiang,
Gleb L. Savich,
Ting Xu Tan,
J. Todd Auman,
Janelle M. Hoskins,
Anne Misher,
C. D. Moser,
Scott Yourstone,
J. W. Kim,
K. Cibulskis,
G. Getz,
Heike Hunt,
S. S. Thorgeirsson,
L. R. Roberts,
D. Ye,
K. L. Guan,
Yin Xiong,
L. X. Qin,
Derek Y. Chiang
Publication year - 2013
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/5wp4-fd43
Subject(s) - isocitrate dehydrogenase , idh1 , idh2 , cancer research , dna methylation , pathology , chemistry , medicine , biology , mutation , genetics , gene , enzyme , biochemistry , gene expression
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom